Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05299580
Title Dabrafenib and Trametinib in Circulating Free DNA BRAFV600 Mutated Metastatic Melanoma Patients: a Prospective Phase II, Open Label, Multicentre Study - (Bioliquid TAILOR Study - BIOTAILOR)
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Fondazione Melanoma Onlus
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R.S.T) S.r.l. Meldola Forlì-Cesena 47014 Italy Details
Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo Alessandria Italy Details
National Institute of Cancer Bari 70124 Italy Details
Università degli Studi di Bari Aldo Moro Bari Italy Details
AOU Sant'Orsola-Malpighi Bologna Italy Details
ASST Spedali Civili Brescia Brescia Italy Details
Azienda Sanitaria Ospedaliera S. Croce e Carle Cuneo Italy Details
IRCCS San Martino - IST Genova 16132 Italy Details
Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori Milano 20133 Italy Details
Azienda Ospedaliera Universitaria di Modena Modena Italy Details
Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale" Naples 80131 Italy Details
Istituto Oncologico Veneto Padova 35128 Italy Details
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo Italy Details
Istituto Nazionale Tumori Regina Elena Roma 00144 Italy Details
Azienda Ospedaliera Universitaria - Città della Salute e della Scienza di Torino Torino Italy Details
Azienda Ospedaliera Universitaria Integrata di Udine Udine Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field